Our client was launching a biosimilar for a common health condition and needed to establish baseline metrics for tracking brand performance and perceptions. They needed insights to:
- Assess healthcare professionals’ awareness, trial, and usage of both the new biosimilar and key competitors.
- Explore how stakeholders perceive the interchangeability between the biosimilar and other available treatments.
- Measure product performance including perceived drivers, barriers, and usage intent